However, when a large number of phosphorylated ERKs accumulate in the nucleus, the use of the MEK‐specific blocker U0126 cannot reverse the resistance response of ovarian cancer cells to cisplatin .15 The gene discussed is MAP2K7; the disease is ovarian carcinoma.